Bayer is contesting the FDA's actions in reducing the use of antibiotics
for non-therapeutic purposes, a battle which should tie the hands of the
FDA for years.
The company's slogan, bye the bye, is "Expertise with Responsibility."
Ho, hum. Let us help them understand the meaning of "Expertise with
Responsiblity" at
http://www.bayer.com/kontakt/mailform_ot_en.html
If you prefer to write, the address is:
Bayer AG
51368 Leverkusen
Germany
Werner Wenning has been Chairman of the Board of Management of Bayer AG
since April 26, 2002. He is Chairman of the Board Committee for Corporate
Coordination and a member of the Board Committee for Finance.
Klaus Kühn has been a member of the Board of Management of Bayer AG since
May 1, 2002. He is Chairman of the Board Committee for Finance and a member
of the Board Committees for Corporate Coordination and Human Resources
Dr. Attila Molnar, who was appointed to the Board of Management effective
April 1, 1999, is a member of the Board Committees for Human Resources, and
for Technology and Environment. He is also the representative for the
Agriculture segment and for the North America and Mexico region.
Dr. Frank Morich has been a member of the Board of Management of Bayer AG
since May 1, 2000. He is the representative for the Health Care segment and
Chairman of the Board Committee for Research and Development. He is also a
member of the Board Committees for Marketing, Materials Management and
Information Processing, and for Technology and Environment. Effective July
1, 2002, he will be Chairman of the Board of Management of Bayer HealthCare
AG.
Dr. Udo Oels has been a member of the Board of Management of Bayer AG since
February 1, 1996. He is Chairman of the Board Committee for Technology and
Environment and a member of the Board Committees for Research and
Development and Corporate Coordination. He is also the representative for
the China region.
Dr. Richard Pott has been a member of the Board of Management of Bayer AG
since May 1, 2002. He is Labor Director, Chairman of the Board Committee
for Human Resources and a member of the Board Committees for Research and
Development, and for Marketing, Materials Management and Information
Processing. He is also representative for the Chemicals business segment
and the Europe region.
Werner Spinner was appointed to the Board of Management of Bayer AG
effective February 1, 1998. He is Chairman of the Board Committee for
Marketing, Materials Management and Information Processing and a member of
the Board Committee for Finance. He is also the representative for the
Polymers business segment, the Asia/Pacific region and for Bayer's
corporate eCommerce project.
Strange that a European company would fight U.S. laws when Europeans are so
very aware of the dangers of antibiotic resistance.
Peggy Murdock
|